Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NORSK MEDIKAL A/S
AS
Active
Org 945950331
Kvalamarka 11, 5514 Haugesund
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 1987
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 6,7M
-12% vs 2023
EBITDA margin
5.5%
+153% vs 2023
Equity ratio
36.2%
Financial strength
Net profit 2024
NOK 212K
+119% vs 2023
EBITDA — year on year
NOK millions
1M
1M
0M
-1M
-1M
1M
2020
1M
0%
2021
1M
0%
2022
-1M
-200%
2023
0M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 6,7M
-12%
EBITDA
NOK 368K
+153%
Net profit
NOK 212K
+119%
Total assets
NOK 3,5M
-24%
Equity
NOK 1,3M
+20%
Employees
2
—
Company information
Legal name
NORSK MEDIKAL A/S
Org number
945950331
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23. oktober 1987
Share capital
NOK 1 110 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Contact
Address
Kvalamarka 11, 5514 Haugesund
Phone
+4752704140
Email
mail@norsk-medikal.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Haugesund
All Norway companies
Revenue
NOK millions
0M
3M
7M
10M
14M
11M
2020
12M
2021
12M
2022
8M
2023
7M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
-1M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
11 382
11 922
11 523
7 614
6 729
Staff expenses
−1 368
−1 530
−1 588
−1 556
−700
EBITDA
681
730
645
−700
368
Depreciation & amort.
−32
−24
−65
−63
−59
EBIT
649
706
579
−762
308
Net financials
−167
−58
−146
−154
−97
Profit before tax
482
648
434
−917
212
Tax
106
143
95
226
−0
Net profit
376
505
338
−1 142
212
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
5 152
5 357
5 558
4 599
3 504
Equity
1 354
1 860
2 198
1 056
1 267
Long-term debt
878
723
733
519
190
Short-term debt
2 920
2 774
2 626
3 025
2 046
Total debt
3 798
3 497
3 360
3 544
2 237
Financial ratios
5-year trend
EBITDA margin
5.5%
This company
15.8%
Market median
-65% vs market
2020
2024
Equity ratio
36.2%
This company
38.2%
Market median
+5% vs market
2020
2024
Return on equity
16.7%
This company
18.4%
Market median
+9% vs market
2020
2024
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
2020
2024
Asset turnover
1.92×
This company
1.12×
Market median
+71% vs market
2020
2024
Debt / equity
1.76×
This company
0.62×
Market median
-184% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
EV
Einar Vaardal-Lunde
Chairman
2009
SF
Sigmund Fosse
Board of Directors
2009
HM
Halvor Magne Urrang
Chairman
2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Urrang Holdning As
Company
11.71%
11.71%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Urrang Holdning As
NORSK MEDIKAL A/S
(this company)
Board network connections
Board members of NORSK MEDIKAL A/S also hold positions in
0
other companies.
Person
Role here
Other companies
Einar Vaardal-Lunde
Chairman
0 companies
Sigmund Fosse
Board of Directors
0 companies
Halvor Magne Urrang
Chairman
0 companies